Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures
Publié dansJournal of acquired immune deficiency syndromes, vol. 53, no. 4, p. 464-471
Date de publication2010
Résumé
Mots-clés
- Anti-HIV Agents/ therapeutic use
- Antiretroviral Therapy, Highly Active/ methods
- CD4 Lymphocyte Count
- Female
- HIV Infections/ drug therapy
- Humans
- Male
- Pyrrolidinones/ therapeutic use
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Viral Load
Structure d'affiliation Pas une publication de l'UNIGE
Citation (format ISO)
SCHERRER, A. U. et al. Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures. In: Journal of acquired immune deficiency syndromes, 2010, vol. 53, n° 4, p. 464–471. doi: 10.1097/QAI.0b013e3181bca4ec
Fichiers principaux (1)
Article
Identifiants
- PID : unige:7574
- DOI : 10.1097/QAI.0b013e3181bca4ec
- PMID : 19841590
ISSN du journal1525-4135